Tag: -mul
ASH: Daratumumab Beneficial for Patients With Multiple Myeloma
Addition of daratumumab to VRd results in improved progression-free survival for transplantation-eligible patients
Racial, Ethnic Differences ID’d for Idecabtagene Vicleucel in Multiple Myeloma
Non-Hispanic Black patients more likely to develop cytokine release syndrome; best overall response rate was lower in Hispanics
